Studies have proposed that m6A may promote viral infection by interfering with the type I interferon pathway, as it interferes with the recognition of viral RNA by RIG-I [28] or targets IFN-β mRNA for accelerated degradation [33,37]. This evidence concerns the gene RIGI and viral infectious disease.